JPRN-UMIN000035232
Recruiting
N/A
A phase II clinical trial of neoadjuvant chemoradiation therapy for pancreatic ductal adenocarcinoma - A phase II clinical trial of neoadjuvant chemoradiation therapy for pancreatic ductal adenocarcinoma
Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University0 sites50 target enrollmentDecember 12, 2018
Conditionspancreatic cancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- pancreatic cancer
- Sponsor
- Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients with other active cancers 2\) Patients who can not take medicine orally 3\) Patients with severe allergies 4\) Patients with watery diarrhea 5\) Patients with severe co\-morbid disease 6\) Patients seems inadequate for this study by investigator(s)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
A clinical phase-II trial of neoadjuvant chemoradiotherapy with S-1 and Gemcitabine for locally advanced pancreatic cancer (PerSeUS-GP02)ocally advanced pancreatic cancerJPRN-UMIN000010435PerSeUS: Perpetual Study estimated-by United Sections in gifu40
Completed
Phase 2
A clinical phase-II trial of neoadjuvant chemoradiation therapy using S-1 for locally advanced pancreatic cancer (PerSeUS-GP-01)ocally advanced pancreatic cancerJPRN-UMIN000002176PerSeUS-GP40
Not Yet Recruiting
Phase 1
A phase II clinical trial of neoadjyvant chemoradiation therapy using Gemcitabine combined with IMRT for borderline resectable pancreatic cancerborderline resectable pancreatic cancerJPRN-UMIN000010113Hepato-pamcreato-biliary Surgery and Transplantation, Graduate School of Medicine and Faculty of Medicine KyotoUniversity37
Not Yet Recruiting
N/A
Phase 2 clinical study of neoadjuvant chemotherapy for HER2-negative primary breast cancer patients using dose dense nab-paclitaxel followed by dose dense Epirubicin and cyclophosphamideHER2 negative primary breast cancerJPRN-UMIN000019787Dept of breast oncology50
Completed
Phase 2
A phase II trial of Neoadjuvant and adjuvant chemotherapy with Gemcitabine and TS-1 combination for patients with locally advanced pancreatic cancerpancreatic cancerJPRN-UMIN000005578Chiba study group of adjuvant chemotherapy for pancreatic cancer45